Fibrinogen (Human) (Fibryga)
Fibrinogen (Human) is an FDA-licensed reference biologic from Octapharma Pharmazeutika Produktionsges.m.b.H.. Reference exclusivity, biosimilar lineage, and published patents from official FDA Purple Book records.
0
Biosimilars
0
Interchangeables
0
Listed patents
2017
Reference approved
Reference product
Fibryga Fibrinogen (Human)
Octapharma Pharmazeutika Produktionsges.m.b.H.
- Approved
- Jun 07, 2017
- Marketing
- Rx
- Center
- CBER
- Patents
- None listed
Exclusivity & patent cliffs
Approval, exclusivity, and published-patent expiration dates for Fibrinogen (Human), in chronological order.
Reference approval
Approval date of the reference Fibrinogen (Human) product.
9 yr 1 mo ago
Frequently asked questions
Are there biosimilars approved for Fibrinogen (Human) (Fibryga)?
No 351(k) biosimilars or interchangeable biosimilars referencing Fibrinogen (Human) are listed in the FDA Purple Book yet.
Explore the full FDA Purple Book
Search every FDA-licensed biologic, biosimilar, and interchangeable with exclusivity timelines and patent records.
